CNS vs FHI
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 30, 2026
CNS
FHI
Investment Advisor Scores
FHI
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CNS | FHI | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 22.779 | 11.3895 | FHI |
| PEG Ratio | 2.033 | 2.3242 | CNS |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 12.2% | 13.1% | FHI |
| Earnings Growth | 31.9% | 1.6% | CNS |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 52.8/100 | 51.1/100 | CNS |
| Profit Margin | 28.8% | 21.5% | CNS |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CNS
MarkupPrice above SMA50, rising 50-day trend (5.5% over 20 days), RSI 66
FHI
MarkupPrice above SMA50, rising 50-day trend (2.6% over 20 days), RSI 70
Fundamentals Snapshot
| Metric | CNS | FHI |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 21.8 | 10.9 |
| Trailing P/E | 25.3 | 11.1 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.2% |
| Gross Margin | 0.5% | 0.7% |
| Operating Margin | 0.3% | 0.3% |
| EPS | 3.25 | 5.38 |
| Dividend Yield | 0.03% | 0.02% |